IRIS
NAPOLITANO, CARLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.403
AS - Asia 6.474
EU - Europa 4.890
SA - Sud America 913
AF - Africa 201
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 10
Totale 20.905
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.243
CN - Cina 3.277
SG - Singapore 1.377
IE - Irlanda 1.114
HK - Hong Kong 712
BR - Brasile 669
UA - Ucraina 669
DE - Germania 527
RU - Federazione Russa 508
IT - Italia 501
VN - Vietnam 477
FI - Finlandia 386
FR - Francia 380
SE - Svezia 352
GB - Regno Unito 249
IN - India 126
AR - Argentina 86
CA - Canada 78
ZA - Sudafrica 78
BD - Bangladesh 76
JP - Giappone 72
IQ - Iraq 53
MX - Messico 48
PK - Pakistan 46
EC - Ecuador 35
ID - Indonesia 34
NL - Olanda 34
CO - Colombia 32
VE - Venezuela 30
AT - Austria 29
ES - Italia 24
JO - Giordania 23
PH - Filippine 23
UZ - Uzbekistan 23
PL - Polonia 22
MA - Marocco 21
MU - Mauritius 21
BE - Belgio 19
TR - Turchia 19
PY - Paraguay 16
SA - Arabia Saudita 15
AE - Emirati Arabi Uniti 14
CL - Cile 14
KZ - Kazakistan 14
MY - Malesia 14
KE - Kenya 13
PE - Perù 13
TN - Tunisia 13
EG - Egitto 10
AZ - Azerbaigian 9
CZ - Repubblica Ceca 9
JM - Giamaica 9
BO - Bolivia 8
DZ - Algeria 8
NP - Nepal 8
PT - Portogallo 8
UY - Uruguay 8
AL - Albania 7
IR - Iran 7
LT - Lituania 7
ET - Etiopia 6
IL - Israele 6
KW - Kuwait 6
NI - Nicaragua 6
SN - Senegal 6
AU - Australia 5
EU - Europa 5
GE - Georgia 5
GR - Grecia 5
RS - Serbia 5
BA - Bosnia-Erzegovina 4
CH - Svizzera 4
GT - Guatemala 4
KR - Corea 4
NO - Norvegia 4
NZ - Nuova Zelanda 4
OM - Oman 4
PS - Palestinian Territory 4
BH - Bahrain 3
BW - Botswana 3
BY - Bielorussia 3
CR - Costa Rica 3
HU - Ungheria 3
KH - Cambogia 3
LV - Lettonia 3
MD - Moldavia 3
ML - Mali 3
PA - Panama 3
RO - Romania 3
XK - ???statistics.table.value.countryCode.XK??? 3
AM - Armenia 2
BB - Barbados 2
BN - Brunei Darussalam 2
BS - Bahamas 2
CG - Congo 2
CI - Costa d'Avorio 2
CW - ???statistics.table.value.countryCode.CW??? 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
HN - Honduras 2
Totale 20.860
Salva come PNG Salva come JPEG
Città #
Dublin 1.113
Chandler 1.040
San Jose 946
Jacksonville 856
Ashburn 721
Nanjing 718
Hong Kong 699
Singapore 658
Dallas 570
Beijing 474
Boardman 402
Nanchang 301
Princeton 259
Lauterbourg 233
Lawrence 233
Wilmington 222
Hebei 219
Changsha 192
Shenyang 188
Los Angeles 178
Ho Chi Minh City 173
Jiaxing 152
Medford 148
New York 126
Helsinki 124
Tianjin 122
Hanoi 118
Shanghai 114
Moscow 104
Milan 102
Council Bluffs 94
Buffalo 92
Hangzhou 88
Woodbridge 82
Redondo Beach 80
San Genesio Ed Uniti 69
Ann Arbor 63
Tokyo 62
Santa Clara 60
São Paulo 59
Johannesburg 57
Norwalk 47
Falls Church 46
Falkenstein 44
Verona 42
Chicago 40
Munich 40
Orem 40
Brooklyn 39
Seattle 39
The Dalles 39
San Francisco 34
Houston 33
Nuremberg 33
Pavia 29
Des Moines 27
Chennai 26
Da Nang 25
Guangzhou 24
Montreal 24
Frankfurt am Main 23
Toronto 23
Zhengzhou 23
Kunming 22
Amman 21
Atlanta 21
Tashkent 21
Columbus 19
Fairfield 19
Warsaw 19
Mexico City 18
Rio de Janeiro 18
Stockholm 18
Baghdad 17
Brussels 17
Jinan 17
London 17
Thái Nguyên 17
Washington 17
Dhaka 16
Haiphong 16
Lahore 16
Boston 15
Curitiba 15
Denver 15
Guayaquil 15
Phoenix 15
Rome 15
Amsterdam 14
Naples 14
Palermo 14
Mumbai 12
Ningbo 12
Brasília 11
Buenos Aires 11
Nairobi 11
Tappahannock 11
Turku 11
Vienna 11
Belo Horizonte 10
Totale 13.629
Salva come PNG Salva come JPEG
Nome #
From decision to shared-decision: Introducing patients' preferences into clinical decision analysis. 190
Tachicardia Ventricolare Polimorfa Catecolaminergica 172
A method of gene transfer for the treatment of recessive CPVT 170
Arrhythmogenic mechanisms in a mouse model of Catecholaminergic Polymorphic Ventricular Tachycardia. 166
A cardiac arrhythmia syndrome caused by loss of ankyrin-B function 160
Graphical Representation of Life Paths to Better Convey Results of Decision Models to Patients. 147
Genetic testing in the long QT syndrome: development and validation of an efficient approach to genotyping in clinical practice 143
Interplay Between Genetic Substrate, QTc Duration, and Arrhythmia Risk in Patients With Long QT Syndrome 140
Arrhythmogenic Right Ventricular Cardiomyopathy: Clinical Course and Predictors of Arrhythmic Risk 134
Natural History and Risk Stratification in Andersen-Tawil Syndrome Type 1 131
Abnormal Calcium Signalling and Sudden Cardiac Death Associated With Mutation of Calsequestrin. 130
[Computerized tomography study of 32 patients with disk hernia confirmed during surgical intervention]. 130
Assessment of a personalized and distributed patient guidance system 129
A Molecular Link between the Sudden Infant Death Syndrome and the Long-QT Syndrome. 129
A newly charactarized SCN5A mutation underlying Brugada Syndrome unmasked by Hyperthermia 129
Gene-specific therapy for inherited arrhythmogenic diseases 128
Computer simulation of wild-type and mutant human cardiac Na+ current 127
Efficacy and Limitations of Quinidine in Patients with Brugada Syndrome 127
Hydroquinidine Prevents Life-Threatening Arrhythmic Events in Patients With Short QT Syndrome 125
Sympathetic activation, ventricular repolarization and Ikr blockade: implications for the antifibrillatory efficacy of potassium channel blocking agents 124
Allele-Specific Silencing of Mutant mRNA Rescues Ultrastructural and Arrhythmic Phenotype in Mice Carriers of the R4496C Mutation in the Ryanodine Receptor Gene (RYR2). 124
Abnormal Interactions of Calsequestrin With the Ryanodine Receptor Calcium Release Channel Complex Linked to Exercise-Induced Sudden Cardiac Death 124
Combining decision support system-generated recommendations with interactive guideline visualization for better informed decisions 122
Risk stratification in the Long-QT Syndrome 119
Clinical timelines development from textual medical reports in Italian 119
Patient-tailored Workflow Patterns from Clinical Practice Guidelines Recommendations. 118
Gene-specific therapy with mexiletine reduces arrhythmic events in patients with long QT syndrome type 3 118
CARDIO-i2b2: integrating arrhythmogenic disease data in i2b2. 117
A Recessive Variant of the Romano-Ward Long QT Syndrome 116
Association of Hydroxychloroquine with QTc Interval in Patients with COVID-19 115
FKBP12.6 deficiency and defective calcium release channel (ryanodine receptor) function linked to exercise-induced sudden cardiac death. 114
La sindrome di Brugada: epidemiologia, stratificazione del rischio e management clinico. 114
[Role of standard resting ECG in the assessment of sudden cardiac death risk] 113
Genotype-Phenotype correlation in the Long QT Syndrome. Gene-specific triggers for life-threatening arrhythmias 112
A novel form of short QT syndrome (SQT3) is caused by a mutation in the KCNJ2 gene. 112
Information extraction from Italian medical reports: An ontology-driven approach 112
Increased Ca2+ Sensitivity of the Ryanodine Receptor Mutant RyR2R4496C Underlies Catecholaminergic Polymorphic Ventricular Tachycardia. 111
Interplay between Clinical Guidelines and Organizational Workflow Systems. Experience from the MobiGuide project 111
Abnormal Propagation of Calcium Waves and Ultrastructural Remodeling in Recessive Catecholaminergic Polymorphic Ventricular Tachycardia. 110
Big Data as a Driver for Clinical Decision Support Systems: A Learning Health Systems Perspective 110
Clinical profile and genetic basis of Brugada syndrome in the Chinese population. 109
Fever-related arrhythmic events in the multicenter Survey on Arrhythmic Events in Brugada Syndrome 109
CardioVAI: An automatic implementation of ACMG-AMP variant interpretation guidelines in the diagnosis of cardiovascular diseases 108
Age and sex-related differences in the clinical manifestations of congenital long QT syndrome: findings from the International Prospective LQTS Registry 107
Cardiac Sodium Channel Diseases 106
Calmodulin kinase II inhibition prevents arrhythmias in RyR2(R4496C+/-) mice with catecholaminergic polymorphic ventricular tachycardia. 106
Supporting shared decision making within the MobiGuide project. 106
Clinical presentation and outcome of Brugada syndrome diagnosed with the new 2013 criteria 105
A molecular basis for the therapy of the long QT syndrome 105
CaMKII inhibition rectifies arrhythmic phenotype in a patient-specific model of catecholaminergic polymorphic ventricular tachycardia. 104
Genetic modulators of the phenotype in the long QT syndrome: state of the art and clinical impact 104
Loss of function associated with novel mutations of the SCN5A gene in patients with Brugada syndrome 102
Arrhythmogenesis in Catecholaminergic Polymorphic Ventricular Tachycardia: insights from a RyR2 R4496C knock-in mouse model 102
The role of nurses in e-health: The MobiGuide project experience 102
Risk of aborted cardiac arrest or sudden cardiac death during adolescence in the long-QT syndrome. 101
R Engine Cell: integrating R into the i2b2 software infrastructure. 101
Evaluation of BLS-D training in lay people. 100
Diagnosis and treatment of catecholaminergic polymorphic ventricular tachycardia. 100
Programmed ventricular stimulation for risk stratification in the Brugada syndrome: A pooled analysis 100
Genetics of ion-channel disorders 99
Clinical utility gene card for: Catecholaminergic polymorphic ventricular tachycardia (CPVT). 98
Cardiac Magnetic Resonance in Stable Coronary Artery Disease: Added Prognostic Value to Conventional Risk Profiling 98
Policy statement: ESC-ERC recommendations for the use of automated external defibrillators (AEDs) in Europe. 97
Inherited arrhythmia: present and future perspectives for genetic therapy 97
The long QT syndrome 97
Cardiac ryanodine receptor calcium release deficiency syndrome 97
Single delivery of an adeno-associated viral construct to transfer the CASQ2 gene to knock-in mice affected by catecholaminergic polymorphic ventricular tachycardia is able to cure the disease from birth to advanced age 96
MobiGuide: a personalized and patient-centric decision-support system and its evaluation in the atrial fibrillation and gestational diabetes domains 96
Bidirectional Ventricular Tachycardia and Fibrillation Elicited in a Knock-In Mouse Model Carrier of a Mutation in the Cardiac Ryanodine Receptor (RyR2) 96
Supervised methods to extract clinical events from cardiology reports in Italian 96
Evaluation of spatial aspects of T-wave complexity in the Long QT syndrome 95
Unexpected Risk Profile of a Large Pediatric Population With Brugada Syndrome 95
Information Extraction from Italian medical reports: first steps towards clinical timelines development 94
Gating Properties of SCN5A Mutations and the Response to Mexiletine in Long-QT Syndrome Type 3 Patients 94
Association of long QT syndrome loci and cardiac events among patients treated with beta-blockers 93
Epinephrine unmasks latent mutation carriers with LQT1 form of congenital long-QT syndrome. 92
Genetic of Long QT, Brugada and Other Channelopathies 92
Yield of Genetic Screening in Inherited Cardiac Channelopathies. 92
Viral Gene Transfer Rescues Arrhythmogenic Phenotype and Ultrastructural Abnormalities in Adult Calsequestrin-Null Mice With Inherited Arrhythmias 92
L-TYPE CALCIUM CHANNEL DISEASE 92
Clinical and research data integration: the i2b2-FSM experience 92
Brugada syndrome 92
Molecular and electrophysiological bases of catecholaminergic polymorphic ventricular tachycardia. 91
Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism 91
Timothy Syndrome 91
Inherited calcium channelopathies in the pathophysiology of arrhythmias. 91
Flecainide test in Brugada Syndrome: a reproducible but risky tool 91
In the RyR2R4496C Mouse Model of CPVT, {beta}-Adrenergic Stimulation Induces Ca Waves by Increasing SR Ca Content and Not by Decreasing the Threshold for Ca Waves. 90
Experimental Therapy of genetic arrhythmias: disease-specific pharmacology. 89
Gene-specific differences in the circadian variation of ventricular repolarization in the long QT syndrome: a key to sudden death during sleep? 89
Gender Differences in Patients with Brugada Syndrome and Arrhythmic Events: Data from a Survey on Arrhythmic Events in 678 Patients. 89
The usual suspects in sudden cardiac death of the young: a focus on inherited arrhythmogenic diseases 88
Age of First Arrhythmic Event in Brugada Syndrome: Data From the SABRUS (Survey on Arrhythmic Events in Brugada Syndrome) in 678 Patients 88
Long QT Syndrome 87
Genetics of Arrhythmogenic Disorders 87
Catecholaminergic Polymorphic Ventricular Tachycardia 87
Adeno-associated virus-mediated CASQ2 delivery rescues phenotypic alterations in a patient-specific model of recessive catecholaminergic polymorphic ventricular tachycardia 87
Outcomes of Patients With Catecholaminergic Polymorphic Ventricular Tachycardia Treated With β-Blockers 87
Sodium current disorders: Geneticist's view 86
La tachicardia ventricolare polimorfa catecolaminergica 86
Totale 10.896
Salva come PNG Salva come JPEG
Categoria #
all - tutte 92.787
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 92.787
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.003 8 2 16 6 27 55 34 59 82 51 155 508
2022/20233.090 363 193 42 260 289 350 2 146 1.298 18 78 51
2023/20241.169 137 175 55 103 107 315 53 63 5 24 36 96
2024/20253.129 58 271 68 88 78 155 191 286 717 128 288 801
2025/20267.008 525 486 919 669 783 301 1.369 268 547 655 283 203
2026/2027149 149 0 0 0 0 0 0 0 0 0 0 0
Totale 21.077